Patrick Waters
Contact information
01865 227840
Patrick Waters
PhD
Senior Postdoctoral Research Scientist
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Websites
-
NHS Specialised Services for Neuromyelitis optica
NHS Specialised Services for Neuromyelitis optica
-
Guthy-Jackson NMO Website
Guthy-Jackson NMO Website
-
Eugene Devic European Network
EDEN Project
-
Associate Faculty Member of F1000
F1000
Key publications
-
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
Journal article
Carvajal-González A. et al, (2014), Brain, 137, 2178 - 2192
-
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Journal article
Kitley J. et al, (2014), JAMA NEUROLOGY, 71, 276 - 283
-
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Journal article
Waters PJ. et al, (2012), Neurology, 78, 665 - 671
-
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Journal article
Irani SR. et al, (2010), Brain, 133, 1655 - 1667
-
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.
Journal article
Hutchinson M. et al, (2008), Neurology, 71, 1291 - 1292
Recent publications
-
Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.
Journal article
Kim S-M. et al, (2017), Mult Scler, 23, 1104 - 1111
-
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
Journal article
Lang B. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 353 - 361
-
G2A1B3AA receptor antibodies and their clinical associations.
Journal article
Waters PJ. and Irani SR., (2017), Neurology, 88, 1010 - 1011
-
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.
Journal article
Juryńczyk M. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 132 - 136
-
Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.
Journal article
Tackley G. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 165 - 169